Related Experiment Videos
Engineering of bypass conduits to improve patency
S T Rashid1, H J Salacinski, B J Fuller
1Biomaterials and Tissue Engineering Centre, University Department of Surgery, Royal Free and University College Medical School, University College London, Royal Free Hospital, London, UK.
Cell Proliferation
|September 21, 2004
Summary
New surgical bypass materials are needed for severe vascular disease. This review explores reducing prosthetic graft issues and the potential of tissue-engineered vessels using peptides for better cell adhesion.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Regenerative Medicine
Background:
- Severe coronary artery and peripheral vascular disease patients lack viable bypass options.
- Current prosthetic grafts have limitations, with no significant material advancements in decades.
- Autologous vessels are often insufficient for complex bypass procedures.
Purpose of the Study:
- To review current challenges in surgical bypass materials for complex vascular disease.
- To explore strategies for improving prosthetic graft performance.
- To examine the potential of tissue-engineered vascular grafts (TEVGs).
Main Methods:
- Literature review of existing and emerging bypass graft technologies.
- Analysis of methods to reduce prosthetic graft thrombogenicity.
- Investigation of peptide-based strategies for enhancing cell adhesion in TEVGs.
Main Results:
- Endothelial cell seeding and novel prosthetic materials show promise in reducing thrombogenicity.
- Tissue-engineered blood vessels offer a potential alternative to traditional grafts.
- Peptides can significantly improve cell adhesion to scaffold materials.
Conclusions:
- There is a critical need for advanced surgical bypass materials.
- Reducing prosthetic graft thrombogenicity is a key area for improvement.
- Tissue engineering, particularly with peptide-enhanced scaffolds, holds significant promise for future vascular reconstruction.